Effects of photobiomodulation therapy in strength training and detraining in humans

• Grant number: 18/21982-0
• Support Opportunities: Regular Research Grants
• Start date: August 01, 2019
• End date: January 31, 2022
• Field of knowledge: Interdisciplinary Subjects
• Principal Investigator: Ernesto Cesar Pinto Leal Junior
• Grantee: Ernesto Cesar Pinto Leal Junior
• Host Institution: Universidade Nove de Julho (UNINOVE). Campus Vergueiro. São Paulo , SP, Brazil

Abstract

In the last years it has been demonstrated that photobiomodulation therapy (PBMT) has ergogenic effects, improving muscular performance and accelerating post-exercise recovery. However, many aspects related to these effects and its' clinical applicability remain unknown. Therefore, the aim of this project is to evaluate the ergogenic effects of PBMT in detraining after a strength training protocol. For such, it will be carried out a randomized, triple-blind, placebo-controlled clinical trial. In this study it will be analyzed the muscular strength and the structural properties of quadriceps. We believe that the results from this project can represent an important step for the wide clinical use of PBMT as an ergogenic agent. (AU)

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

TOMAZONI, SHAIANE SILVA; BJORDAL, JAN MAGNUS; LEAL-JUNIOR, ERNESTO CESAR PINTO. Similar Is Not Equal: It Is Time to Create the Perfect Photobiomodulation Storm. PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY, v. 40, n. 4, p. 2-pg., 2022-03-29. (18/21982-0)

VICENTE DE PAIVA, PAULO ROBERTO; CASALECHI, HELIODORA LEAO; TOMAZONI, SHAIANE SILVA; MONTEIRO MACHADO, CAROLINE DOS SANTOS; VANIN, ADRIANE AVER; BARONI, BRUNO MANFREDINI; CAMILLO DE CARVALHO, PAULO DE TARSO; PINTO LEAL-JUNIOR, ERNESTO CESAR. Effects of photobiomodulation therapy combined to static magnetic field in strength training and detraining in humans: protocol for a randomised placebo-controlled trial. BMJ OPEN, v. 9, n. 10, OCT 2019. (18/21982-0, 16/11878-5)